NFKK 2014


Biomarkers in heart disease

P01 Lipoprotein(a), total/HDL-cholesterol ratio, ApoB/ApoA ratio as risk factors for atherogenesis in patients with coronary artery disease

Danica Labudovic, Sonja Alabakovska, Katerina Tosheska Trajkovska, Jasna Bogdanska, Silvana Jovanova


P02 High Sensitive Troponin in patients with Erectile Dysfunction

Gianvico Melzi D´eril, Raffaele Pezzilli, Clara A. L. Damele, Rossana Stefanelli, Giovanni M. Colpi, Massimiliano M. Corsi Romanelli, Alessandra Barassi


P03 Acute pancreatitis and myocardial damage

GianVico Melzi d´Eril, Raffaele Pezzilli, Giovanni M. Colpi, Massimiliano M. Corsi Romanelli, Alessandra Barassi


P04 Quality assurance measurement of the cholesterol markers apolipoproteins A1 and B; Going against the grain

Joannis Kinalis, Eva Fahlen, Erika Langenstam, Erika Karabasic


P05 Evaluation of the Alere NT-proBNP test for point of care testing

Banafsheh Seyyed Khezri, Lena Carlsson, Anders Larsson


P06 Serial Troponin T testing based on stored samples on the clinical laboratory

Oscar  Oliva Torstensson, Carina Gustafsson, Birgitta Gren, Jan Friden, Ola Hammarsten


P07 Implementation of cardiac biomarkers in ambulatory emergency medicine department

Vaike Viia


P07:2 Estimation of the possible economic effects of a sequential testing strategy with NT-proBNP before echocardiography in primary care

Banafsheh  Seyyed Khezri, Johanna Helmersson-Karlqvist, Anders Larsson


Novel techniques

P08 An invitro assay to measure cell sensitivity to ionizing radiation

Sherin Mathew, Pegah Johansson, Ola Hammarsten


P09 An improved high performance liquid chromatography-fluorescence detection method for the analysis of Pimozide in human plasma samples

Alessandra Barassi, Francesca Ghilardi, Alessandra Flaminio, Roberta Marotta, GianVico Melzi d´Eril


P10 Validation of a new OptiScanner™ 5000 system for an intermittent glucose monitoring

Alessandra Barassi, Michele Umbrello, Clara A. L. Damele, Francesca Ghilardi, Rossana Stefanelli, Gaetano Iapichino, GianVico Melzi d´Eril


P11 Preparation and in vitro evaluation of doxorubicin-loaded Fe3O4 magnetic nanoparticles modified with biocompatible copolymers

Abolfazl Akbarzadeh


P12 Amyloidosis diagnosis by mass spectrometry

Jakob C. Albrethsen, Morten Salomo, Anders H. Johnsen


Biomarkers in neurodegenerative disease

P13 Plasma levels of apolipoprotein E and risk of dementia in the general population

Katrine Laura Rasmussen, Anne Tybjærg-Hansen, Børge G. Nordestgaard, Ruth Frikke-Schmidt


P14 Blood biomarkers for brain injury in concussed professional ice hockey players

Pashtun Shahim, Gisela Malmgård, David H. Wilson, Jeffrey Randall, Birgitta Kallberg, Yelverton Tegner, Kaj Blennow, Henrik Zetterberg


P15 Biomarker-determined Alzheimer prevalence in patients undergoing surgery due to hip fracture

Maria Lönnquist, Birgitta Kallberg, Kaj  Blennow, Henrik Zetterberg, Bengt Nellgård


Laboratory as a diagnostic partner

P16 Critical results for community based patients and audit of a two tier biochemical phone list

Jeffrey Barron, Geoff Smith


P17 HbA1c as the diagnostic criterion for diabetes reduces incidence and prevalence of DM2 by 25% but strongly depending on analytical quality

Ivan Brandslund, Aneta A. Nielsen, Per H. Petersen, Anders Green, Cramer K. Christensen, Henry Christensen


P18 Ensuring faster patient treatment by reducing turn-around-time for laboratory results

Carsten Thomsen, Claus Brasen, Christian U. Maegaard, Nina Mogensen, Ivan Brandslund


P19 Vitamin D in patients with pancreatic diseases

Gianvico Melzi D´eril, Alessandra Barassi, Raffaele Pezzilli


P20 Vitamin D and Erectile Dysfunction

Alessandra Barassi, Raffaele Pezzilli, Clara A. L. Damele, Rossana Stefanelli, Giovanni M. Colpi, Massimiliano M. Corsi Romanelli, GianVico Melzi d´Eril



Sonia Distante, Ragnhild Skinnes, Kari  Høie, Lars Mørkrid, Lars Eide

P22 The Role Of Early Evaluation Of Porphyrins In Diagnosis Of Acute Porphyria

Galina Zemtsovskaja, Agnes Ivanov, Marika Pikta


P23 Can Morning Serum Cortisol Ranges and Action Limits be Harmonised?

Robert Wardrop, Narelle Hadlow


P24 An Alpha-Thalassemia Case in Estonia

Marika Pikta, Galina Zemtsovskaja, Iige Viigimaa, Jelena Jerjomina


P25 Use of Pyrosequencing for the Detection of Several Polymorphisms Associated with Lactase Persistence

Catherine Herrera, Gunnhild Kravdahl, Malene Nilsen


Biomarker development

P26 Effect of fasting on plasma levels of 7-alpha-hydroxy-4-cholesten-3-one – a marker for bile acid synthesis in humans

Magnus Axelson, Kerstin Brismar


P27 Detection of antinuclear antibodies – a comparison of indirect immunefluorescence on HEp-2 cells and fluoroenzymeimmunoassay (EliA CTD screen, Thermo Fisher)

Lone Nørgård Troelsen, Søren Jacobsen, Lina Pedersen


P28 Measuring gamma-H2AX as a biomarker for DNA damage after ionizing radiation treatment in cancer patients

Pegah Johansson, Aida  Muslimovic, Ragnar Hultborn, Erik Fernström, Ola Hammarsten



P29 Novel Circulating isoforms of hepcidin

Morten Moe, Tor-Arne Hagve, Ingrid M. Hardang


P30 Early diagnosis and calculating the risk of ovarian cancer in women by combining the results of two biomarkers HE4 & CA125

Aaso Raoofi, Adam Molner, Fereshteh Pourlotfi, Tatyana Danylchenko



P31 Assessment of a diagnostic algorithm to classify von Willebrand disease

Karin Littmann, Maria Berndtsson, Eva-Marie Norberg, Jovan Antovic


P32 Trypan Blue accurately defines the viability of CFU-GM cells in Cord Blood Units

Sofia U. Frändberg, Eva Anghem, Inger Ögärd, Lars Palmqvist


P33 Exploring the heterogeneity of the hematopoietic stem cell pool: A simultaneous staining protocol for the Side population, Aldehyde dehydrogenase and CD34 in Cord Blood

Sofia U. Frändberg, Susann Li, Cecilia Boreström, Lars Palmqvist


P34 Are hemoglobin variants eluting in “variant window” on Bio-Rad Variant Turbo 2.0 affecting the HbA1c results?

Britta Landin, Lena Fredriksson


P35 The usefulness of the “Imm Gran?” flag reported on by the Sysmex XE-5000.

Heidi Eilertsen, Tor-Arne Hagve


P36 Hypersegmentation in a routin laboratory– a common finding or not?

Anna Maj Ericsson, Helena Orre-Ekdahl, Stefan Jacobsson


P37 Evaluation of ‘CellaVision Advanced RBC application’; new software for reporting erythrocyte morphology.

Eva Grönlund, Margit Döry, Agnetha Evers, Soheir Beshara


P38 Interference of Monoclonal Antibody Therapies with Serum Protein Electrophoresis Analysis

Claus Brasen, Jakub Krejcik, Torben Plesner


P39 Whole exome sequencing of sorted leukemic cells as a complementing method in genetic characterization of acute myeloid leukemia

Erik  Malmberg, Sara Ståhlman, Sofie J. Alm, Tore Samuelsson, Lars Palmqvist, Linda Fogelstrand


Point of care testing

P40 Evaluation of HemoCue WBC DIFF system versus Sysmex XE in blood samples from pediatric patients

Anette Friis Larsen, Ole Halfdan Larsen, Anne Dorthe Møller, Søren Ladefoged, Tore Hardlei


P41 Harmonizing POCT and Central Core Laboratory analyzers

Anne-Charlotte Wicktorsson, Maria Thornemo


P41:2 Assuring quality in point-of-care testing at the Sahlgrenska University Hospital

Anne-Marie Johannesson, Ingrid Uttberg, Maria Thornemo


P42 Centralized vs. decentralized blood collection: A comparison of quality indicators for the preanalytical phase.

Erik K. Amundsen, Solrun Fransen, Gro Siri B. Lillesund, Tonje V. Larsen, Karin Toska


P43 Like Herding Cats – Information Technology Facilitates Management of Point of Care Testing Systems

Nicole Carney, Robert Dodds, Katrina Moreau, Gregory Sharp


P44 Evaluation of three different CRP Point of Care Testing instruments

Slavena Mandic, Marie Palmblad, Laura Goobar Larsson


Laboratory education


Jasna Bogdanska, Danica Labudovic


Novel company technology

P46 Keeping Bacteria Under Control to Minimize Impact on Assays and Maximize Analyzer Uptime

Stephane Mabic, Maryse Gauthey Baraou, Johan Thorell



P47 Integrated EQA

Jonna Pelanti, Samuli Niiranen


P48 Method comparison of three automated 25-hydroxy vitamin D enzyme immunoassays to liquid chromatography tandem mass spectroscopy (LCMS/MS) and against each other.

Nada Rakovan, Trine Lauritzen, Per O. Nordstrøm, Øyvind Skadberg


P49 Automated alarm to detect antigen excess in serum free immunoglobulin light chain kappa and lambda assays - Experience from routine application.

Karin Toska, Erik K. Amundsen, Petter Urdal, Olav Klingenberg


P50 Haemolysis in underfilled venipuncture testtubes

Birgitta Gren


P51 Reproducibility problem in an ELISA assay method - fibroblast growth factor 23 (FGF-23) as an example

Henrik Alfthan, Helene Markkanen, Esa Hämäläinen


P52 Efficient extraction of human DNA from stool samples and detection of genetic and epigenetic alterations specific for colorectal neoplasia

Aleksandra Mandic Havelka, Annelie Strålfors, Lars-Olof Hansson, Ulrik Lindfors, Gösta Eggertsen


P53 PAPP-A2. Median values in normal pregnancy in first trimester and association to Small-For-Gestational-Age infants.

Young Bae Hansen, Vibeke Myrhøj, Finn S. Jørgensen, Claus Oxvig, Steen Sørensen


P54 Comparison of two methods for determination of coagulation factor VIII activity

Susanne Samuelsson


P55 Evaluation of Technopath Controls on the ARCHITECT Family of Instruments

Jessie Shih, Didier Brault, Antonio Croce, Lieselotte Lennartz, Matthias Orth


P56 Comparison of the results of immunoglobulin (IgA,IgG,IgM), IgG subclasses and specific antibodies of patients with frequent sinopulmonary problems.

Elo Saue


P57 Clinical chemical monitoring of PFIC-patients treated with a new surgical method

Karin Littmann, Cecilia Gälman, Paolo Parini, Björn Fishler, Antal  Nemeth, Eva Beijer, Maria Magnusson, Ronald Oude-Elferink, Gösta Eggertsen


P58 Hidden asymptomatic CDG cases may be mistaken for excessive alcohol consumption

Anders Helander, Jaak Jaeken, Gert Matthijs, Gösta Eggertsen


P59 Up-regulation of Liver Enriched Transcription Factors (HNF4a and HNF6) and Liver Specific MicroRNA (MiR-122) by Inhibition of Let-7b in Mesenchymal Stem Cells

Nosratollah Zarghami, Effat Alizadeh, Abolfazl Akbarzadeh, Mohamadreza Baghaban Eslaminejad, Kazem Nejati-Koshki


P60 Kidney stone analysis by FTIR

Morten Moe, Marianne Moe, Gunnhild Kravdal


P61 Sigma metrics used to assess analytical quality of clinical chemistry assays: Importance of the allowable total error (TEa) target.

Dave Armbruster, Sten A. Westgard


P62 Inhibitory Effects of β-Cyclodextrin-Helenalin Complexes on H-TERT Gene Expression in the T47D Breast Cancer Cell Line - Results of Real Time Quantitative PCR

Faraz Zarghami, Abolfazl Akbarzadeh


P63 Effect of rest time prior to blood sampling on common biochemical parameter - results from thyreotropin

Ida B. Andersen, Claus L. Brasen, Lene  Nohr-Jensen, Dorthe E. Nielsen, Jonna  S. Madsen



Göran Oleröd, Eva  Klingberg, Jan Konar, Max Petzold , Ola Hammarsten


P65 Effect of apixaban on common coagulation analyses

Inger Fagerberg Blixter and Equalis